We are live on !
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow % of AUM
Cap. Flow %
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held
Equity + Options
3
years
Top 10 Avg Time Held
Equity + Options
2.4
years
Top 20 Avg Time Held
Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.6M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2526
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3K | ﹤0.01% |
52
-35
| -40% | -$1.68K |
2020 Q3
6 quarters
|
|
2527
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $3K | ﹤0.01% |
196
+156
| +390% | +$3.27K |
2021 Q2
3 quarters
|
|
|
CPE
2528
DELISTED
Callon Petroleum Company
CPE
| $3K | ﹤0.01% |
42
-133
| -76% | -$7.28K |
2021 Q2
3 quarters
|
|
|
PGTI
2529
DELISTED
PGT, Inc.
PGTI
| $3K | ﹤0.01% |
+150
| New | +$3.04K |
2022 Q1
0 quarters
|
|
2530
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $3K | ﹤0.01% |
394
-940
| -70% | -$5.98K |
2021 Q3
2 quarters
|
|
|
AMRS
2531
DELISTED
Amyris Inc.
AMRS
| $3K | ﹤0.01% |
780
+750
| +2,500% | +$3.36K |
2021 Q3
2 quarters
|
|
|
CSII
2532
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3K | ﹤0.01% |
115
-27
| -19% | -$524 |
2021 Q4
1 quarter
|
|
2533
DELISTED
Principal Contrarian Value Index ETF
PVAL
| $3K | ﹤0.01% |
100
+50
| +100% | +$1.5K |
2021 Q4
1 quarter
|
|
2534
DELISTED
Vonage Holdings Corporation
VG
| $3K | ﹤0.01% |
171
+37
| +28% | +$757 |
2021 Q1
4 quarters
|
|
2535
Arbutus Biopharma
ABUS
$836M
| $2K | ﹤0.01% |
550
| – | – |
2020 Q3
6 quarters
|
|
2536
Acadia Healthcare
ACHC
$2.79B
| $2K | ﹤0.01% |
27
+3
| +13% | +$174 |
2017 Q4
17 quarters
|
|
2537
Federal Agricultural Mortgage
AGM
$2.21B
| $2K | ﹤0.01% |
16
| – | – |
2021 Q2
3 quarters
|
|
2538
Argan
AGX
$4.85B
| $2K | ﹤0.01% |
40
+18
| +82% | +$705 |
2018 Q1
16 quarters
|
|
2539
Alamo Group
ALG
$1.83B
| $2K | ﹤0.01% |
16
-5
| -24% | -$724 |
2020 Q4
5 quarters
|
|
2540
Ameresco
AMRC
$1.03B
| $2K | ﹤0.01% |
21
-7
| -25% | -$441 |
2021 Q1
4 quarters
|
|
2541
AngioDynamics
ANGO
$473M
| $2K | ﹤0.01% |
93
-57
| -38% | -$1.29K |
2020 Q1
8 quarters
|
|
2542
abrdn Total Dynamic Dividend Fund
AOD
$1.07B
| $2K | ﹤0.01% |
250
| – | – |
2020 Q4
5 quarters
|
|
2543
Anterix
ATEX
$1.58B
| $2K | ﹤0.01% |
37
-6
| -14% | -$328 |
2020 Q2
7 quarters
|
|
2544
ATN International
ATNI
$397M
| $2K | ﹤0.01% |
49
-273
| -85% | -$10.2K |
2016 Q4
21 quarters
|
|
2545
Atara Biotherapeutics
ATRA
$92.1M
| $2K | ﹤0.01% |
8
-5
| -38% | -$1.59K |
2020 Q2
7 quarters
|
|
2546
Mission Produce
AVO
$1.07B
| $2K | ﹤0.01% |
180
-2,920
| -94% | -$38.9K |
2020 Q4
5 quarters
|
|
2547
Benchmark Electronics
BHE
$2.54B
| $2K | ﹤0.01% |
78
+17
| +28% | +$434 |
2018 Q4
13 quarters
|
|
2548
BrightSpire Capital
BRSP
$467M
| $2K | ﹤0.01% |
257
| – | – |
2020 Q2
7 quarters
|
|
2549
DELISTED
BioXcel Therapeutics
BTAI
| $2K | ﹤0.01% |
+5
| New | +$1.45K |
2022 Q1
0 quarters
|
|
2550
Peabody Energy
BTU
$2.91B
| $2K | ﹤0.01% |
89
| – | – |
2021 Q4
1 quarter
|
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.6M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.